After being diagnosed with diabetes, people can be presented with a variety of treatment options. Figuring out which medication is best for a person's specific needs can be challenging, especially when health information seems to be changing all the time.
A recent report by the American Heart Association found that neither Avandia and Actos (rosiglitazone and pioglitazone respectively) produce a significantly different outcome than the other.
"Besides its findings that rosiglitazone and pioglitazone have comparable risks, what distinguishes this latest study from other claims-based analyses is its analysis of death records, which include out-of-hospital deaths," Wertz said.
This study's findings also differ from earlier research which indicated that those who took Avandia had a higher risk of heart attack compared to those taking a placebo.
Some people are more prone to developing diabetes than others. African Americans and Latinos, for example, have been shown to have a higher incidence rate of type 2 diabetes than other population segments. In many cases, diabetes can be avoided through eating a proper diet. Not only does eating a proper diet help reduce the likelihood of developing certain conditions, it may help one save on life insurance.